- Home
- IDAI vs SBFM Comparison
IDAI vs SBFM Comparison
Compare IDAI & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDAI
- SBFM
- Stock Information
- Founded
- IDAI 2016
- SBFM 2006
- Country
- IDAI United States
- SBFM United States
- Employees
- IDAI N/A
- SBFM N/A
- Industry
- IDAI Computer Software: Prepackaged Software
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- IDAI Technology
- SBFM Health Care
- Exchange
- IDAI Nasdaq
- SBFM Nasdaq
- Market Cap
- IDAI 4.9M
- SBFM 7.7M
- IPO Year
- IDAI N/A
- SBFM N/A
- Fundamental
- Price
- IDAI $2.76
- SBFM $1.54
- Analyst Decision
- IDAI
- SBFM Strong Buy
- Analyst Count
- IDAI 0
- SBFM 1
- Target Price
- IDAI N/A
- SBFM $15.00
- AVG Volume (30 Days)
- IDAI 48.2K
- SBFM 183.8K
- Earning Date
- IDAI 08-12-2025
- SBFM 08-15-2025
- Dividend Yield
- IDAI N/A
- SBFM N/A
- EPS Growth
- IDAI N/A
- SBFM N/A
- EPS
- IDAI N/A
- SBFM N/A
- Revenue
- IDAI $3,054,143.00
- SBFM $36,234,578.00
- Revenue This Year
- IDAI $65.46
- SBFM $192.48
- Revenue Next Year
- IDAI $12.00
- SBFM N/A
- P/E Ratio
- IDAI N/A
- SBFM N/A
- Revenue Growth
- IDAI N/A
- SBFM 35.51
- 52 Week Low
- IDAI $1.43
- SBFM $1.17
- 52 Week High
- IDAI $18.75
- SBFM $7.60
- Technical
- Relative Strength Index (RSI)
- IDAI 67.94
- SBFM 53.29
- Support Level
- IDAI $2.50
- SBFM $1.42
- Resistance Level
- IDAI $2.82
- SBFM $1.75
- Average True Range (ATR)
- IDAI 0.26
- SBFM 0.12
- MACD
- IDAI 0.07
- SBFM 0.01
- Stochastic Oscillator
- IDAI 71.85
- SBFM 44.44
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.